ED90 for Hyperbaric Bupivacaine in Super Obese Parturients

Completed · Phase 4

Conditions studied: Obesity, Morbid, Spinal Anesthesia, Cesarean Delivery

In brief

The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.

Key facts

Study ID

NCT03781388

Run by

Duke University

People needed

45

Starts

2019-05-01

Expected to finish

2022-12-06

Last updated by the study team

2026-04-17

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• American Society of Anesthesiology (ASA) class 2 and 3
• English speaking
• Gestational age > 36 weeks
• Scheduled for cesarean delivery under combined spinal epidural anesthesia
• 18 years or older
• BMI > 50 kg/m2

You may not qualify if…

• History of past or current intravenous drug or chronic opioid abuse
• Allergy or contraindication to any study medications
• Intrapartum cesarean delivery under epidural anesthesia
• Cesarean delivery under general anesthesia

Where it is running

• Duke University Hospital — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.